|
1
|
Hollinger FB and Liang TJ: Hepatitis B
virus. Fields Virology. Knipe DM and Howley PM: Lippincott Williams
& Wilkins; Philadelphia: pp. 2971–3036. 2001
|
|
2
|
Wu YH, Hao BJ, Cao HC, Xu W, Li YJ and Li
LJ: Anti-hepatitis B virus effect and possible mechanism of action
of 3,4-o-dicaffeoylquinic acid in vitro and in vivo. Evid Based
Complement Alternat Med. 2012:3568062012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delaney WE IV, Locarnini S and Shaw T:
Resistance of hepatitis B virus to antiviral drugs: current aspects
and directions for future investigation. Antivir Chem Chemother.
12:1–35. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maines MD, Trakshel GM and Kutty RK:
Characterization of two constitutive forms of rat liver microsomal
heme oxygenase. Only one molecular species of the enzyme is
inducible. J Biol Chem. 261:411–419. 1986.PubMed/NCBI
|
|
5
|
Maines MD: Heme oxygenase: function,
multiplicity, regulatory mechanisms, and clinical applications.
FASEB J. 2:2557–2568. 1988.PubMed/NCBI
|
|
6
|
Otterbein LE and Choi AM: Heme oxygenase:
colors of defense against cellular stress. Am J Physiol Lung Cell
Mol Physiol. 279:L1029–L1037. 2000.PubMed/NCBI
|
|
7
|
Sass G, Barikbin R and Tiegs G: The
multiple functions of heme oxygenase-1 in the liver. Z
Gastroenterol. 50:34–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Protzer U, Seyfried S, Quasdorff M, et al:
Antiviral activity and hepatoprotection by heme oxygenase-1 in
hepatitis B virus infection. Gastroenterology. 133:1156–1165. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sells MA, Chen ML and Acs G: Production of
hepatitis B virus particles in Hep G2 cells transfected with cloned
hepatitis B virus DNA. Proc Natl Acad Sci USA. 84:1005–1009. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
11
|
Tenhunen R, Marver HS and Schmid R: The
enzymatic conversion of heme to bilirubin by microsomal heme
oxygenase. Proc Natl Acad Sci USA. 61:748–755. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tenhunen R, Marver H, Pimstone NR, Trager
WF, Cooper DY and Schmid R: Enzymatic degradation of heme.
Oxygenative cleavage requiring cytochrome P-450. Biochemistry.
11:1716–1720. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yachie A, Niida Y, Wada T, Igarashi N,
Kaneda H, Toma T, Ohta K, Kasahara Y and Koizumi S: Oxidative
stress causes enhanced endothelial cell injury in human heme
oxygenase-1 deficiency. J Clin Invest. 103:129–135. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawashima A, Oda Y, Yachie A, Koizumi S
and Nakanishi I: Heme oxygenase-1 deficiency: the first autopsy
case. Hum Pathol. 33:125–130. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schulz S, Wong RJ, Jang KY, Kalish F,
Chisholm KM, Zhao H, Vreman HJ, Sylvester KG and Stevenson DK: Heme
oxygenase-1 deficiency promotes the development of necrotizing
enterocolitis-like intestinal injury in a newborn mouse model. Am J
Physiol Gastrointest Liver Physiol. 304:G991–G1001. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Immenschuh S, Baumgart-Vogt E and Mueller
S: Heme oxygenase-1 and iron in liver inflammation: a complex
alliance. Curr Drug Targets. 11:1541–1550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zuckerbraun BS, Billiar TR, Otterbein SL,
Kim PK, Liu F, Choi AM, Bach FH and Otterbein LE: Carbon monoxide
protects against liver failure through nitric oxide-induced heme
oxygenase 1. J Exp Med. 198:1707–1716. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sass G, Soares MC, Yamashita K, Seyfried
S, Zimmermann WH, Eschenhagen T, Kaczmarek E, Ritter T, Volk HD and
Tiegs G: Heme oxygenase-1 and its reaction product, carbon
monoxide, prevent inflammation-related apoptotic liver damage in
mice. Hepatology. 38:909–918. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sass G, Seyfried S, Parreira Soares M,
Yamashita K, Kaczmarek E, Neuhuber WL and Tiegs G: Cooperative
effect of biliverdin and carbon monoxide on survival of mice in
immune-mediated liver injury. Hepatology. 40:1128–1135. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang KY, Tsai PS, Huang TY, Wang TY, Yang
S and Huang CJ: HO-1 mediates the effects of HBO pretreatment
against sepsis. J Surg Res. 136:143–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wen T, Guan L, Zhang YL and Zhao JY:
Dynamic changes of heme oxygenase-1 and carbon monoxide production
in acute liver injury induced by carbon tetrachloride in rats.
Toxicology. 228:51–57. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wen T, Wu ZM, Liu Y, Tan YF, Ren F and Wu
H: Upregulation of heme oxygenase-1 with hemin prevents
D-galactosamine and lipopolysaccharide-induced acute hepatic injury
in rats. Toxicology. 237:184–193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barikbin R, Neureiter D, Wirth J, Erhardt
A, Schwinge D, Kluwe J, Schramm C, Tiegs G and Sass G: Induction of
heme oxygenase 1 prevents progression of liver fibrosis in Mdr2
knockout mice. Hepatology. 55:553–562. 2012. View Article : Google Scholar
|
|
24
|
Nan Y, Wang R, Zhao S, Han F, Wu WJ, Kong
L, Fu N, Kong L and Yu J: Heme oxygenase-1 prevents non-alcoholic
steatohepatitis through suppressing hepatocyte apoptosis in mice.
Lipids Health Dis. 9:1242010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu J, Chu ES, Wang R, Wang S, Wu CW, Wong
VW, Chan HL, Farrell GC and Sung JJ: Heme oxygenase-1 protects
against steatohepatitis in both cultured hepatocytes and mice.
Gastroenterology. 138:694–704. 2010. View Article : Google Scholar
|
|
26
|
McCarter SD, Badhwar A, Scott JR, Akyea
TG, Bihari A, Dungey AA, Harris KA and Potter RF: Remote liver
injury is attenuated by adenovirus-mediated gene transfer of heme
oxygenase-1 during the systemic inflammatory response syndrome.
Microcirculation. 11:587–595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Amersi F, Buelow R, Kato H, Ke B, Coito
AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, et al:
Upregulation of heme oxygenase-1 protects genetically fat Zucker
rat livers from ischemia/reperfusion injury. J Clin Invest.
104:1631–1639. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amersi F, Shen XD, Anselmo D, Melinek J,
Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, et al: Ex vivo
exposure to carbon monoxide prevents hepatic ischemia/reperfusion
injury through p38 MAP kinase pathway. Hepatology. 35:815–823.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kato H, Amersi F, Buelow R, Melinek J,
Coito AJ, Ke B, Busuttil RW and Kupiec-Weglinski JW: Heme
oxygenase-1 overexpression protects rat livers from
ischemia/reperfusion injury with extended cold preservation. Am J
Transplant. 1:121–128. 2001. View Article : Google Scholar
|
|
30
|
Kim SJ, Park JG and Lee SM: Protective
effect of heme oxygenase-1 induction against hepatic injury in
alcoholic steatotic liver exposed to cold ischemia/reperfusion.
Life Sci. 90:169–176. 2012. View Article : Google Scholar
|
|
31
|
Abraham NG and Kappas A: Pharmacological
and clinical aspects of heme oxygenase. Pharmacol Rev. 60:79–127.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y,
Chen L, Chen Y, Duan Z and Meng S: miR-122-induced down-regulation
of HO-1 negatively affects miR-122-mediated suppression of HBV.
Biochem Biophys Res Commun. 398:771–777. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown
KE, Luxon BA and Schmidt WN: Heme oxygenase-1 suppresses hepatitis
C virus replication and increases resistance of hepatocytes to
oxidant injury. Hepatology. 48:1430–1439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lehmann E, El-Tantawy WH, Ocker M,
Bartenschlager R, Lohmann V, Hashemolhosseini S, Tiegs G and Sass
G: The heme oxygenase 1 product biliverdin interferes with HCV
replication by increasing antiviral interferon response.
Hepatology. 51:398–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shan Y, Zheng J, Lambrecht RW and
Bonkovsky HL: Reciprocal effects of micro-RNA-122 on expression of
heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.
Gastroenterology. 133:1166–1174. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chang J, Nicolas E, Marks D, Sander C,
Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, Zaret KS
and Taylor JM: miR-122, a mammalian liver-specific microRNA, is
processed from hcr mRNA and may downregulate the high affinity
cationic amino acid transporter CAT-1. RNA Biol. 1:106–113. 2004.
View Article : Google Scholar
|
|
37
|
Lee J, Lee SK, Lee BU, Lee HJ, Cho NP,
Yoon JH, Choi HR, Lee SK and Kim EC: Upregulation of heme
oxygenase-1 in oral epithelial dysplasias. Int J Oral Maxillofac
Surg. 37:287–292. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nuhn P, Künzli BM, Hennig R, Mitkus T,
Ramanauskas T, Nobiling R, Meuer SC, Friess H and Berberat PO: Heme
oxygenase-1 and its metabolites affect pancreatic tumor growth in
vivo. Mol Cancer. 8:372009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sass G, Leukel P, Schmitz V, Raskopf E,
Ocker M, Neureiter D, Meissnitzer M, Tasika E, Tannapfel A and
Tiegs G: Inhibition of heme oxygenase 1 expression by small
interfering RNA decreases orthotopic tumor growth in livers of
mice. Int J Cancer. 123:1269–1277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sureau C, Romet-Lemonne JL, Mullins JI and
Essex M: Production of hepatitis B virus by a differentiated human
hepatoma cell line after transfection with cloned circular HBV DNA.
Cell. 47:37–47. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Elbirt KK and Bonkovsky HL: Heme
oxygenase: recent advances in understanding its regulation and
role. Proc Assoc Am Physicians. 111:438–447. 1999.PubMed/NCBI
|
|
42
|
Wiegand J, Wedemeyer H, Finger A, Heidrich
B, Rosenau J, Michel G, Bock CT, Manns MP and Tillmann HL: A
decline in hepatitis B virus surface antigen (hbsag) predicts
clearance, but does not correlate with quantitative hbeag or HBV
DNA levels. Antivir Ther. 13:547–554. 2008.PubMed/NCBI
|
|
43
|
Lin L and Hu J: Inhibition of hepadnavirus
reverse transcriptase-epsilon RNA interaction by porphyrin
compounds. J Virol. 82:2305–2312. 2008. View Article : Google Scholar :
|
